267 related articles for article (PubMed ID: 12730369)
1. Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing.
Ekstrand AJ; Cao R; Bjorndahl M; Nystrom S; Jonsson-Rylander AC; Hassani H; Hallberg B; Nordlander M; Cao Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):6033-8. PubMed ID: 12730369
[TBL] [Abstract][Full Text] [Related]
2. Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent.
Nilsson T; Lind H; Brunkvall J; Edvinsson L
Can J Physiol Pharmacol; 2000 Mar; 78(3):251-5. PubMed ID: 10721817
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
Soscia SJ; Harrington ME
Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
[TBL] [Abstract][Full Text] [Related]
4. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor.
Naveilhan P; Hassani H; Canals JM; Ekstrand AJ; Larefalk A; Chhajlani V; Arenas E; Gedda K; Svensson L; Thoren P; Ernfors P
Nat Med; 1999 Oct; 5(10):1188-93. PubMed ID: 10502824
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide Y does not reset the circadian clock in NPY Y2-/- mice.
Soscia SJ; Harrington ME
Neurosci Lett; 2005 Jan; 373(3):175-8. PubMed ID: 15619538
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium.
Zukowska-Grojec Z; Karwatowska-Prokopczuk E; Rose W; Rone J; Movafagh S; Ji H; Yeh Y; Chen WT; Kleinman HK; Grouzmann E; Grant DS
Circ Res; 1998 Jul; 83(2):187-95. PubMed ID: 9686758
[TBL] [Abstract][Full Text] [Related]
7. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
[TBL] [Abstract][Full Text] [Related]
8. Tetraiodothyroacetic acid, a small molecule integrin ligand, blocks angiogenesis induced by vascular endothelial growth factor and basic fibroblast growth factor.
Mousa SA; Bergh JJ; Dier E; Rebbaa A; O'Connor LJ; Yalcin M; Aljada A; Dyskin E; Davis FB; Lin HY; Davis PJ
Angiogenesis; 2008; 11(2):183-90. PubMed ID: 18080776
[TBL] [Abstract][Full Text] [Related]
9. Platelet-activating factor (PAF) induces corneal neovascularization and upregulates VEGF expression in endothelial cells.
Ma X; Ottino P; Bazan HE; Bazan NG
Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2915-21. PubMed ID: 15326102
[TBL] [Abstract][Full Text] [Related]
10. Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function.
Gehlert DR; Shaw JL
Peptides; 2007 Feb; 28(2):241-9. PubMed ID: 17208335
[TBL] [Abstract][Full Text] [Related]
11. Receptor autoradiography as mean to explore the possible functional relevance of neuropeptides: focus on new agonists and antagonists to study natriuretic peptides, neuropeptide Y and calcitonin gene-related peptides.
Dumont Y; Chabot JG; Quirion R
Peptides; 2004 Mar; 25(3):365-91. PubMed ID: 15134861
[TBL] [Abstract][Full Text] [Related]
12. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis.
Caunt M; Hu L; Tang T; Brooks PC; Ibrahim S; Karpatkin S
Cancer Res; 2006 Apr; 66(8):4125-32. PubMed ID: 16618733
[TBL] [Abstract][Full Text] [Related]
13. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
14. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
15. Human peripheral blood eosinophils induce angiogenesis.
Puxeddu I; Alian A; Piliponsky AM; Ribatti D; Panet A; Levi-Schaffer F
Int J Biochem Cell Biol; 2005 Mar; 37(3):628-36. PubMed ID: 15618019
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
[TBL] [Abstract][Full Text] [Related]
17. Distribution of neuropeptide Y Y1 receptors in rodent peripheral tissues.
Matsuda H; Brumovsky PR; Kopp J; Pedrazzini T; Hökfelt T
J Comp Neurol; 2002 Aug; 449(4):390-404. PubMed ID: 12115674
[TBL] [Abstract][Full Text] [Related]
18. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
19. Tracking adult neovascularization during ischemia and inflammation using Vegfr2-LacZ reporter mice.
Heidenreich R; Murayama T; Silver M; Essl C; Asahara T; Rocken M; Breier G
J Vasc Res; 2008; 45(5):437-44. PubMed ID: 18418002
[TBL] [Abstract][Full Text] [Related]
20. Chimeric VEGF-E(NZ7)/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation.
Zheng Y; Murakami M; Takahashi H; Yamauchi M; Kiba A; Yamaguchi S; Yabana N; Alitalo K; Shibuya M
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2019-26. PubMed ID: 16794222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]